StockData
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX) stock

FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30
$1.79−0.28 (-13.53%)

Close on Nov 16, 2026Market cap $106.30MP/E –Yield –

Foghorn Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Foghorn Therapeutics's market cap was $122.71M on Nov 11, 2026, against $268.58M a year earlier. Over the last 5 years it ranged from $122.13M to $847.21M, with a median of $282.15M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$122.71M-59.8%
2025Dec 31, 2025$305.33M+16.4%
2024Dec 31, 2024$262.40M-3.6%
2023Dec 29, 2023$272.30M+2.1%
2022Dec 30, 2022$266.68M-68.5%
2021Dec 31, 2021$847.21M+594.2%
2020Dec 31, 2020$122.05M–

More Foghorn Therapeutics figures

See a number that looks wrong?